Access
This article is part of Nature's premium content.
Published online 18 June 2008 | Nature | doi:10.1038/453962a
Japan ramps up patent effort to keep iPS lead
United States in race to commercialize pluripotent stem cells.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
